A man living with cancer died after being given multiple overdoses of morphine
Clinical
Aim To explore the impact of gynaecological cancer on se
<p>Myeloproliferative neoplasms are chronic haematological disorders and many patien
<p>This article reports the findings of a re-audit across a cancer network of the im
<p>A project involving the introduction of a new discharge pathway has been recognis
<p>This article discusses normal bone remodelling and explains how this changes when
<p>This article reports the results of a patient satisfaction questionnaire used to
<p>This integrated thematic literature review explored men’s experiences of urinary
<p>This article discusses the implications of introducing novel treatments into clin
<p>The breast cancer risk assessment service (BCRAS) at Guy’s Hospital, London, prov
<p>Clinical supervision is an effective way to provide support to staff.
<p>Chemotherapy-related cognitive deficits in adult patients with colorectal cancer,
<p>This article briefly describes what is meant by ‘targeted cancer treatments’ and
<p>National Institute for Health and Clinical Excellence (2004) guidance for improving supportive and palliative care for adults with cancer identified a need for specialist teams to provide face-to-face patient assessment seven days a week.
<p>An audit of mortality figures for patients undergoing chemotherapy for urothelial malignancies identified three deaths as a result of neutropenic sepsis in the authors’ centre.
<p>Bournemouth is the setting for the Grove Hotel, which caters for guests with cancer and other life-limiting illnesses, and their carers and families. The hotel is a non-profit venture, owned by local charity Macmillan Caring Locally.
<p>A prospective, multinational study conducted in the United States, Europe, Australia and Canada found the risk of oral mucositis to be as high as 99 per cent in patients with oral cavity or oropharynx tumours and 98 per cent in patients with tumours of the larynx or hypopharynx (Elting e
<p>New and emerging treatments with the potential to extend survival are reshaping and extending the management pathway for men with metastatic castration-resistant prostate cancer.
<p>The advice presented in this article reflects the consensus opinion of research and oncology nurses and a clinical trials practitioner involved in managing patients with metastatic malignant melanoma.
